Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial
NCT ID: NCT03342495
Last Updated: 2023-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
337 participants
INTERVENTIONAL
2018-02-06
2021-09-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will provide urgently needed data to guide health care providers and policy makers regarding the provision of coordinated transition care. These results have the potential to:
1. Change care delivery
2. Improve health outcomes
3. Improve the experiences of young adult transition to adult care
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults
NCT00255944
Evaluating the El Camino Program
NCT06485284
Navigating Mental Health Treatment for Black Youth
NCT05334381
Exploring the Outcomes of System Supports for Youth With Mental Illness and/or Addictions and Their Families
NCT03765281
Innovative Approaches for Minor Consent: Consent 2.0
NCT03242954
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical practice guidelines for transition to adult care recommend the use of patient navigators to coordinate the entry of patients into a complex and unfamiliar adult health care system. Patient navigators provide individualized supports to facilitate medical follow-up and adherence. A limited number of studies have shown that access to a patient navigator during transition decreases drop-out from medical care and disease specific adverse events. No study to date has evaluated the benefits of a patient navigator to improve patient and or health system outcomes, when implemented across multiple chronic disease settings.
Objectives/Methods
1. to evaluate the impact of a patient navigator intervention compared to treatment as usual for 16 to 21 year olds living with chronic health conditions who are transferring to adult care with respect to healthcare utilization and patient reported outcomes
2. to obtain perceptions of stakeholders regarding the role of patient navigators in reducing barriers to adult-oriented ambulatory care
3. to determine the net health care cost impact attributable to the navigator intervention
A qualitative study sampling participants randomized into the intervention arm at the beginning and end of the trial will also be undertaken to understand the patient experience.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Navigator Arm
Patient Navigator (Social Worker) will assist youth adapt and attach to adult delivered healthcare for up to 24 months.
Participants will receive 5 issues of a provincial generic newsletter on topics around transition.
Participants will be asked to complete a health questionnaire at baseline and 4 more times during 24 months.
Participants will be asked to complete a transition readiness questionnaire at baseline and 4 more times during 24 months.
Participants will be provided the opportunity to journal online about their experiences.
Up to 100 participants will be provided the opportunity to be interviewed at baseline and end of study about their transition experience.
Patient Navigator
Social worker/Patient Navigator will be assigned to follow youth in adult care for up to 24 months to assist youth adapt and attach to adult delivered healthcare
Usual Care Arm
Youth will receive usual care from their pediatric clinics in preparation and transfer to adult care.
Participants will receive 5 issues of a provincial generic newsletter on topics around transition.
Participants will be asked to complete a health questionnaire at baseline and 4 more times during 24 months.
Participants will be asked to complete a transition readiness questionnaire at baseline and 4 more times during 24 months.
Participants will be provided the opportunity to journal online about their experiences.
Usual Care
Whatever processes are in place in a variety of clinics to support transfer from pediatric to adult care in the pediatric clinics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient Navigator
Social worker/Patient Navigator will be assigned to follow youth in adult care for up to 24 months to assist youth adapt and attach to adult delivered healthcare
Usual Care
Whatever processes are in place in a variety of clinics to support transfer from pediatric to adult care in the pediatric clinics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Last planned pediatric visit within up to 12 months after assessment of eligibility
Exclusion Criteria
* moving out of province within 24 months
* enrolled in another transition navigator study
16 Years
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alberta Health services
OTHER
University of Alberta
OTHER
University of Calgary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Samuel, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Calgary
Gina Dimitropoulos, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Calgary
Andrew Mackie, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alberta
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alberta Children's Hospital
Calgary, Alberta, Canada
Glenrose Rehabilitation Hospital
Edmonton, Alberta, Canada
Stollery Childrens Hospital
Edmonton, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Samuel S, Punjwani Z, San Martin-Feeney D, Allemang B, Guilcher GMT, Lang E, Pacaud D, Pinzon J, Andrew G, Zwaigenbaum L, Perrott C, Andersen J, Hamiwka L, Nettel-Aguirre A, Klarenbach S, McBrien K, Scott SD, Patton M, Samborn S, Pfister K, Ryan L, Dimitropoulos G, Mackie AS. Effectiveness of Patient Navigation During Transition to Adult Care: A Randomized Clinical Trial. JAMA Pediatr. 2025 Apr 1;179(4):375-382. doi: 10.1001/jamapediatrics.2024.6192.
Lalji R, Koh L, Francis A, Khalid R, Guha C, Johnson DW, Wong G. Patient navigator programmes for children and adolescents with chronic diseases. Cochrane Database Syst Rev. 2024 Oct 9;10(10):CD014688. doi: 10.1002/14651858.CD014688.pub2.
Samuel S, Dimitropoulos G, Schraeder K, Klarenbach S, Nettel-Aguirre A, Guilcher G, Pacaud D, Pinzon J, Lang E, Andrew G, Zwaigenbaum L, Scott S, McBrien K, Hamiwka L, Mackie A. Pragmatic trial evaluating the effectiveness of a patient navigator to decrease emergency room utilisation in transition age youth with chronic conditions: the Transition Navigator Trial protocol. BMJ Open. 2019 Dec 10;9(12):e034309. doi: 10.1136/bmjopen-2019-034309.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB16-2561
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.